Figure S1 from Preclinical Antitumor Efficacy of a Novel Anti–c-Kit Antibody–Drug Conjugate, NN3201, in c-Kit–Positive Tumors

Chansik Kim; Jinwoo Park; Jin-Ock Kim; Han‐Jik Ko; Jin Gu Cho; Yeonjy Lee; Jina Lee; TaeMin Wi; Jiwoo Moon; Sohyeon Park; Jaeyoung Song; Sun-Hwa Lee; Gong Sung; Sang Gyu Park

doi:10.1158/1535-7163.30986129

Figure S1 from Preclinical Antitumor Efficacy of a Novel Anti–c-Kit Antibody–Drug Conjugate, NN3201, in c-Kit–Positive Tumors

2026 Open access

Read full text

Authors: Chansik Kim, Jinwoo Park, Jin-Ock Kim, Han‐Jik Ko, Jin Gu Cho, Yeonjy Lee, Jina Lee, TaeMin Wi, Jiwoo Moon, Sohyeon Park, Jaeyoung Song, Sun-Hwa Lee

+2 more

Gong Sung, Sang Gyu Park

DOI: 10.1158/1535-7163.30986129

Cited by: 1

Abstract

Antibody effector function and FcgR bindings of NN3201

Fields of Study & Subjects

HER2/EGFR in Cancer Research Gastrointestinal Tumor Research and Treatment Radiopharmaceutical Chemistry and Applications

Publication details

Publisher: American Association for Cancer Research (AACR)
Publication date: 2 January 2026